Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
M
Maria Grazia Valsecchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
458
Papers
22.7K
Citations
76
h-index
244
i10-index
Maria Grazia Valsecchi is an academic researcher from Azienda Ospedaliera San Gerardo. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Childhood Cancer Survivors' Quality of Life & Chronic Myeloid Leukemia Treatments. The author has an h-index of 76, co-authored 390 publications.
ORCID: 0000-0001-5574-3504Papers by this author
worksMapping the human genetic architecture of COVID-19
2021 · Nature · 1,104 citations
https://doi.org/10.1038/s41586-021-03767-x
Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study
2022 · American Journal of Respiratory and Critical Care Medicine · 150 citations
https://doi.org/10.1164/rccm.202111-2575oc
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak
2021 · Critical Care · 87 citations
https://doi.org/10.1186/s13054-021-03502-y
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2023 · Genome Medicine · 77 citations
https://doi.org/10.1186/s13073-023-01173-8
Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements
2004 · Leukemia · 51 citations
https://doi.org/10.1038/sj.leu.2403613
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat